Here are five observations:
1. An increasing number of obese people with spinal cord complications and a rising number of minimally invasive spine surgery cases will spur market growth.
2. Procedure costliness, unfavorable reimbursement and a strict product approval process will hinder spinal stenosis market growth.
3. North America and Europe dominate the market because of increasing geriatric populations with spinal disorders.
4. Asia Pacific will witness the highest growth rate because of increasing economic wealth.
5. Key market players include Medtronic, DePuy Synthes, Stryker, Orthofix International, NuVasive, Zimmer Biomet, Globus Medical, Alphatec Holdings, K2M Group Holdings and LDR Holding.
More articles on spine:
How obesity affects spine surgery cost, quality of life: 6 key notes
8 things for spine surgeons to know for Thursday — July 14, 2016
Top 10 most-liked spine surgeons on the internet
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
